Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 11Pancreatic Neoplasms 6Nasopharyngeal Carcinoma 5Cholangiocarcinoma 4Biliary Tract Neoplasms 4Rectal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Cirrhosis, Familial, with Pulmonary Hypertension 3Stomach Neoplasms 2Neoplasm Metastasis 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Neuroendocrine 2Urinary Bladder Neoplasms 1Rare Tumour 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1PDAC - Pancreatic Ductal Adenocarcinoma 1Neoplasms, Second Primary 1Neoplasms 1Neoplasm, Residual 1Neoadjuvant Chemotherapy 1Muscle Neoplasms 1Locally Advanced Low Rectal Adenocarcinoma 1Liver Neoplasms 1Liver Metastases of Colorectal Cancer 1Keratosis, Actinic 1HER2-positive Gastric Cancer 1Gastrointestinal Neoplasms 1

Interventions

spartalizumab 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Locally Advanced Low Rectal Adenocarcinoma × Fluorouracil × Clear all
NCT07277842 2025-12-11

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Sun Yat-sen University

Phase 3 Not yet recruiting
382 enrolled
Gastrointestinal

Locally Advanced Low Rectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡